Aqueous Vernomia amygdalina Extracts Alter MCF-7 Cell Membrane Permeability and Efflux

Michael M. Opata and Ernest B. Izevbigie
Additional contact information
Michael M. Opata: The Laboratory of Phytoceuticals, and Cancer Prevention and Therapies, Jackson State University, 1400 J. R. Lynch Street, P.O Box 18540, Jackson, MS 39217, USA
Ernest B. Izevbigie: The Laboratory of Phytoceuticals, and Cancer Prevention and Therapies, Jackson State University, 1400 J. R. Lynch Street, P.O Box 18540, Jackson, MS 39217, USA

IJERPH, 2006, vol. 3, issue 2, 1-6

Abstract: Breast cancer is the second leading cause of cancer related deaths of women in the United States. Several treatment strategies have been developed over the past decade to reduce cancer morbidity and mortality rates. While mortality rates have declined in some ethnic populations, the overall cancer incidence continues to grow. Hence, chemotherapeutic agents are needed to improve cancer treatment outcome. Previous studies show that low concentrations (microgram/ml) of water-soluble leaf extracts of a Nigerian edible plant, V. amygdalina (VA), potently retard the proliferative activities of estrogen receptor positive (ER+) human breast cancerous cells (MCF-7) cells in vitro in a concentration-dependent fashion. The anti-proliferative activities of VA are extracellular signal-regulated kinases 1/2 (ERKs 1/2)-dependent. Cell culture and animal model studies, conducted by other investigators using other plant extracts, have also revealed that plant extract components called thionins may be responsible for their anticancer activities. These thionins are believed to interact with the cells in ways that compromise membrane potential/permeability resulting in the alteration of efflux, cytosolic activities, and subsequent cell death. Therefore, we hypothesized that VA exposure may compromise cell membrane as another mode of action to elicit its anticancer activities in MCF-7 cells. The exposure of cells to VA decreased [ 3 H]thymidine uptake in a concentration-dependent (0, 30, and 100 ?g/ml VA) manner (p 3 H]thymidine release, expressed as percent of [ 3 H]thymidine incorporated, into the medium (p

Keywords: Breast cancer cells; Vernonia amygdalina; membrane permeability; efflux (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2006
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/3/2/174/pdf (application/pdf)
https://www.mdpi.com/1660-4601/3/2/174/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:3:y:2006:i:2:p:174-179:d:2384

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().